Navigation Links
Studies Presented at International Conference on Alzheimer's Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimer's Disease
Date:7/14/2009

ver pairs showed an exponential relationship between total costs and AD dependence levels, with costs increasing significantly with increasing dependence. In this study, dependence level provided a useful method to estimate unique levels of care and associated costs that can be used in pharmacoeconomic evaluations of new treatments for AD patients in a transparent and meaningful manner.

Poster #P1-180: Relationship Between Patient Dependence and Caregiver Burden in Alzheimer's Disease (Lacey LA, et al.)

A new, longitudinal, non-interventional study that included 155 Alzheimer's disease patients/caregiver pairs across the U.S. and Europe assessed the relationship of AD patients' dependence on caregiver burden, connecting the impact of worsening AD severity on family members or other caregivers. This is the first study exploring the relationship between dependence and caregiver-reported burden via the Caregiver Reaction Assessment, a tool that captures both negative and positive reactions of giving care in an informal setting. Specifically, this poster presented an interim analysis that found caregivers reported experiencing increased disruption in daily schedules, greater lack of family support, and more time devoted to being a caregiver as AD patients' dependence increased.

"Given these recent findings, it's vital for continued research, measurement, and documentation of the growing burden of care and cost of Alzheimer's disease to adequately provide support for caregivers and assess patient healthcare needs," said Dr. Dale P. Schenk, Executive Vice President and Chief Scientific Officer of Elan. "Elan and Wyeth, through the Alzheimer's Immunotherapy Program (AIP), are committed to advancing research in all aspects of the disease."

Poster #P2-071: Increased Risk of Serious Comorbidities in a Cohort of AD Patients Compared to a Similar Non
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
2. Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine
3. iCardiac Selected for Multiple Cardiac Safety Studies
4. Proteolix Presents Clinical Data from Two Clinical Studies of Carfilzomib in Multiple Myeloma at the 14th Congress of the European Hematology Association
5. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
6. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
7. Results From Neurotechs NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors
8. Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
9. Spectros T-Stat Tissue Oximeter Clinical Studies Presented at PAS (Pediatric Academic Societies) Conference
10. Lilly Set to Unveil More Than 50 Studies at ASCO 2009
11. Avoiding False Positives Key Priority in Cardiac Safety Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Nektar Therapeutics (Nasdaq: NKTR ... appointed to serve on its board of directors. ... with over 35 years of experience in corporate ... to Nektar extensive industry perspective at an important ... Robin, President and CEO of Nektar and member ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused ... therapeutics for cardiovascular and muscle disease, today announced ... plays a crucial role in the progression of ... and in neuromuscular synaptic regeneration in mice. ... of the journal Science , reveal miR-206 ...
(Date:12/11/2009)... Dec. 11 Ambit Biosciences Corporation announced today ... M. D. Anderson Cancer Center of the first patient ... E fficacy) Phase 2 pivotal trial ... (AML). AC220 is a novel, orally available, potent ... as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ...
Breaking Biology Technology:Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5
... with a one-two punch of an acquisition and a merger ... grow its GE Medical Systems division. But in ... giant to make additional acquisitions in order to own market ... bought into, according to a company spokesperson. , ,On Oct. ...
... business conditions provide a golden opportunity to tune your ... appear to have calmed, the long-term winners will be ... winning strategies. Real competitive advantage comes from making ... fundamentally aligning your talent management practice to that choice, ...
... still going on in the Midwest at places like the Maytag ... story on Monday. There are many experts giving opinions about why ... jobs are going overseas for cheaper wages and most stop there ... stop because many companies are so focused on the bottom line. ...
Other Biology Technology:GE Medicals Acquisitions May Prompt More Purchases 2GE Medicals Acquisitions May Prompt More Purchases 3Talent Constellations or Talent Communities Choosing the Right Talent 2Talent Constellations or Talent Communities Choosing the Right Talent 3Spend Money to Make Money and Dump Obsolete Tech Strategies 2Spend Money to Make Money and Dump Obsolete Tech Strategies 3Spend Money to Make Money and Dump Obsolete Tech Strategies 4
(Date:12/14/2009)... of an international team that has used DNA samples ... history of North America,s woolly mammoths and ancient horses. ... Atmospheric Sciences professor Duane Froese and his colleagues counters ... bones and teeth. That analysis concluded that more than ... ,megafauna,) disappeared about 13,000 years ago. , In ...
(Date:12/14/2009)... be transmitted by sneezing, touching, or for Tasmanian ... habit that may have driven the dinosaurs to extinction ... Upcroft, a member of f1000 Biology, highlights the ,paleobiological ... PLoS One. This led them to deduce that a ... bones seen in many tyrannosaurid fossils. , The parasite,s ...
(Date:12/14/2009)... team of researchers from the Astrobiology Centre (INTA-CSIC) has ... essential to the formation of the most basic biological ... In order to carry out this study, published in ... recreated the chemical conditions of the early Earth. , ... in ammoniac solutions it produces hydrogen cyanide, a substance ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Mesa Labs Reports Higher First Quarter Earnings 54256 1Mesa Labs Reports Higher First Quarter Earnings 54256 2Mesa Labs Reports Higher First Quarter Earnings 54256 3Mesa Labs Reports Higher First Quarter Earnings 54256 4Mesa Labs Reports Higher First Quarter Earnings 54256 5Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2Lifeline Vascular Access Launches New Platform for Physicians to Share Best Practices and Improve Vascular Access Care 54253 1Lifeline Vascular Access Launches New Platform for Physicians to Share Best Practices and Improve Vascular Access Care 54253 2
... A study by UC Irvine ecologists finds that ... an average of 20 percent, countering the belief that ... Faster plant growth means the tropics will take in ... effects are unclear. Over the next century, nitrogen pollution ...
... Biosensor and Imaging Center have developed new fluorogen ... component of novel molecular biosensor technology being created ... used to monitor biological activities of individual proteins ... time, are described in the February issue of ...
... Quest Product Development, teaming with,Ball Aerospace & ... successfully demonstrated a new thermal insulation. NASA has ... II grant to develop and,commercialize this advanced thermal ... NASA,s new,spacecraft and exploration missions would preserve rocket ...
Other Biology News:Nitrogen pollution boosts plant growth in tropics by 20 percent 2Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design 2Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design 3Colorado Engineering Firms Win NASA Grant to Develop Innovative Insulation for Next Generation Spacecraft - Super-Insulation May Allow Future Energy Efficient Appliances 2
BlotGel application pool -see Blotters (Semi-Dry) for more info...
... described by end-users to be "a delight ... of light microscopy and electronic imaging. With ... does not require much space and can ... environment. The DM-BA300 combines Motic's own revolutionary ...
Request Info...
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
Biology Products: